Risk-Adjusted Outcomesa
| . | OR and/or RR (95% CI) . | P . |
|---|---|---|
| Primary outcome | ||
| Surgical drainage | .28 (.22–.36) | <.001 |
| Secondary outcomes | ||
| Diagnostic evaluation | ||
| >1 CT scan performed | 1.7 (1.18–2.44) | .006 |
| Medical management | ||
| IV fluid hydration | .94 (.78–1.13) | .507 |
| IV analgesia | .93 (.74–1.15) | .477 |
| Opioid analgesia | .75 (.61–.92) | .008 |
| Health care use | ||
| LOS, h | .97 (.92–1.02) | .285 |
| Cost | .92 (.88–.97) | .004 |
| 7-d ED revisit | 2.24 (1.24–4.05) | .009 |
| 30-d hospital readmission | 1.36 (.82–2.27) | .232 |
| . | OR and/or RR (95% CI) . | P . |
|---|---|---|
| Primary outcome | ||
| Surgical drainage | .28 (.22–.36) | <.001 |
| Secondary outcomes | ||
| Diagnostic evaluation | ||
| >1 CT scan performed | 1.7 (1.18–2.44) | .006 |
| Medical management | ||
| IV fluid hydration | .94 (.78–1.13) | .507 |
| IV analgesia | .93 (.74–1.15) | .477 |
| Opioid analgesia | .75 (.61–.92) | .008 |
| Health care use | ||
| LOS, h | .97 (.92–1.02) | .285 |
| Cost | .92 (.88–.97) | .004 |
| 7-d ED revisit | 2.24 (1.24–4.05) | .009 |
| 30-d hospital readmission | 1.36 (.82–2.27) | .232 |
IV, intravenous.
Age, severity index (H-RISK), and antibiotic regimen were included in the risk-adjusted analysis.